Secondary Logo

Institutional members access full text with Ovid®

Calcified neoatherosclerosis causing in-stent restenosis

prevalence, predictors, and implications

Garcia-Guimaraes, Marcosa,b; Antuña, Paulaa,b; Maruri-Sanchez, Ramona,b; Vera, Albertoa,b; Cuesta, Javiera,b; Bastante, Teresaa,b; Rivero, Fernandoa,b; Alfonso, Fernandoa,b

doi: 10.1097/MCA.0000000000000669
Coronary Atherosclerosis
Buy

Background Neoatherosclerosis has emerged as a major cause of in-stent restenosis (ISR). Although this entity has been described as a unique process, optical coherence tomography (OCT) enables depiction of distinct morphologic patterns, including the presence of calcified sheets within the stent. We sought to assess prevalence, predictors, and implications of calcified neoatherosclerosis (cNA) as the cause of ISR.

Methods and results From January 2014 to August 2016, 75 consecutive patients with 81 ISR lesions with a clinical indication for revascularization were evaluated by OCT before reintervention. In 13 (16%) lesions, cNA was the predominant pattern of ISR, all of them presenting as very-late (>3 years) ISR. Patients with cNA were older (71±9 vs. 66±10 years, P=0.0157), had worse low-density lipoprotein control (97±29 vs. 81±30 mg/dl, P=0.0746), and received treatment with statins (54 vs. 85%, P=0.006) and angiotensin-converting-enzyme inhibitors/angiotensin receptor blockers (ACEi/ARB) (31 vs. 65%, P=0.003) less frequently compared with patients with other patterns of ISR. Time from stent implantation to ISR [odds ratio (OR)=1.3; 95% confidence interval (CI): 1.1–1.6; P=0.01] and absence of treatment with statins (OR=11.3; 95% CI: 1.7–74; P=0.012) or ACEi/ARB (OR=7.4; 95% CI: 1.3–43; P=0.026) were associated independently with the presence of cNA. During reinterventions, ISR lesions with cNA obtained poorer angiographic (postintervention minimal lumen diameter 1.8±0.4 vs. 2.2±0.5 mm, P=0.0174) and OCT (final stent expansion 83±11 vs. 88±9%, P=0.0896) results.

Conclusion In our cohort of consecutive patients with clinical ISR, one-sixth showed underlying cNA as the predominant substrate of restenosis. This unique underlying substrate is related to the time elapsed from stent implantation and the absence of previous treatment with statins or ACEi/ARB and is associated with poorer acute results after reintervention.

aCardiology Department

bInstituto de Investigación Sanitaria, Hospital Universitario de La Princesa, Madrid, Spain

Correspondence to Fernando Alfonso, MD, PhD, Departamento de Cardiología, Hospital Universitario de La Princesa, IIS-IP, Universidad Autónoma de Madrid, c/ Diego de León 62, Madrid 28006, Spain Tel: +34 915 202 470; fax: +34 915 202 201; e-mail: falf@hotmail.com

Received September 1, 2018

Received in revised form September 11, 2018

Accepted September 18, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.